The cannabis market has not reached the high that everyone thought it would. Since its legalization on October 17th, 2018, the stock market has not been kind to cannabis companies, as many of the major producers have seen a sharp decline.
“It had an incredible run up. So I think what we’re seeing is the other side of the mountain near where, just like every other cycle, that we’ve seen in capital markets in the last 20 or 30 years and beyond,” said Indiva CEO and President Niel Marotta.
The lackluster stocks coincide with the feeling out process that the cannabis industry has seen. With varying supply issues, an insufficient amount of stores and poor delivery times, the pot market has seen its fair share of bumps in the road.
The cannabis industry will see a new element put in the mix as companies start to release products for what’s being called cannabis 2.0. Health Canada announced on the one year anniversary of its legalization that it would be accepting applications from companies, who intend to produce cannabis-derived goods such as edibles, beverages, and vaping products.
With the implementation of these new and tasty products, it’s expected that the pot market will have a resurgence, similar to the market when marijuana was first legalized.
“Cannabis 2.0 products whether they’re edibles or concentrates or vape products, you name it. These are really big important parts of mature markets, in the United States it makes upwards of 50% plus of the market,” said Marotta.
The London based Indiva, like many other cannabis producers, will have new products hit the shelves over the next couple of weeks. Items like chocolate, sugar, and salt will be available containing THC and CBD. When asked about vaping products, Marotta explained the company will not be releasing any due to the health concerns that have been seen over the last couple of months.
